GABRIEL ZAPATA: Open Payments
NPI 1710380274 · FRESNO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,489 in 26 payments from 10 companies in 2025. Trend: 2023 $1,284 · 2024 $1,300 · 2025 $1,489
Food & beverage: $1,489
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 8 | $392 |
| LEO Pharma Inc. | 5 | $291 |
| Incyte Corporation | 3 | $156 |
| Galderma Laboratories, L.P. | 4 | $149 |
| E.R. Squibb & Sons, L.L.C. | 1 | $125 |
| Arcutis Biotherapeutics, Inc. | 1 | $125 |
| Regeneron Healthcare Solutions, Inc. | 1 | $102 |
| Novartis Pharmaceuticals Corporation | 1 | $91 |
| GENZYME CORPORATION | 1 | $35 |
| Janssen Scientific Affairs, LLC | 1 | $22 |
Products named: ADBRY, OPZELURA, NEMLUVIO, SKYRIZI, DUPIXENT, Sotyktu, RINVOQ, Zoryve.
Industry payments across CA — which companies pay providers there.
